NTLA
Price
$32.39
Change
-$0.27 (-0.83%)
Updated
Mar 4, 6:59 PM EST
59 days until earnings call
SANA
Price
$11.27
Change
+$1.23 (+12.25%)
Updated
Mar 1, 6:59 PM EST
64 days until earnings call
Ad is loading...

Compare trend and price NTLA vs SANA

Header iconNTLA vs SANA Comparison
Open Charts NTLA vs SANABanner chart's image
Intellia Therapeutics
Price$32.39
Change-$0.27 (-0.83%)
Volume$976.59K
CapitalizationN/A
Sana Biotechnology
Price$11.27
Change+$1.23 (+12.25%)
Volume$3.37M
CapitalizationN/A
View a ticker or compare two or three
NTLA vs SANA Comparison Chart

Loading...

NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
NTLA vs. SANA commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongBuy and SANA is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (NTLA: $32.66 vs. SANA: $11.27)
Brand notoriety: NTLA and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 102% vs. SANA: 131%
Market capitalization -- NTLA: $3.14B vs. SANA: $2.47B
NTLA [@Biotechnology] is valued at $3.14B. SANA’s [@Biotechnology] market capitalization is $2.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, both NTLA and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 6 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 6 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than SANA.

Price Growth

NTLA (@Biotechnology) experienced а +25.13% price change this week, while SANA (@Biotechnology) price change was +36.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.10%. For the same industry, the average monthly price growth was +19.06%, and the average quarterly price growth was +53.41%.

Reported Earning Dates

NTLA is expected to report earnings on May 02, 2024.

SANA is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($3.14B) has a higher market cap than SANA($2.47B). SANA YTD gains are higher at: 176.226 vs. NTLA (7.117). SANA has higher annual earnings (EBITDA): -266.82M vs. NTLA (-506.32M). NTLA has more cash in the bank: 912M vs. SANA (269M). SANA has less debt than NTLA: SANA (96.9M) vs NTLA (115M). NTLA has higher revenues than SANA: NTLA (36.3M) vs SANA (0).
NTLASANANTLA / SANA
Capitalization3.14B2.47B127%
EBITDA-506.32M-266.82M190%
Gain YTD7.117176.2264%
P/E RatioN/AN/A-
Revenue36.3M0-
Total Cash912M269M339%
Total Debt115M96.9M119%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLASANA
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IHOVX18.550.22
+1.20%
Hartford International Opportunities R6
FXAIX178.681.43
+0.81%
Fidelity 500 Index
THOIX34.720.18
+0.52%
Thornburg Global Opportunities I
JSVTX15.330.08
+0.52%
Janus Henderson Small-Mid Cap Value T
GCVUX23.740.12
+0.51%
Goldman Sachs Large Cp Val Insghts R6

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.68%
BEAM - NTLA
77%
Closely correlated
+0.89%
EDIT - NTLA
70%
Closely correlated
+4.67%
VCYT - NTLA
70%
Closely correlated
+1.91%
DNLI - NTLA
63%
Loosely correlated
+5.46%
DNA - NTLA
59%
Loosely correlated
-15.13%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+12.25%
CRSP - SANA
60%
Loosely correlated
-0.56%
NTLA - SANA
55%
Loosely correlated
+1.68%
BEAM - SANA
52%
Loosely correlated
+0.89%
EDIT - SANA
50%
Loosely correlated
+4.67%
NRIX - SANA
47%
Loosely correlated
+9.80%
More